Kindbody's Partner-Driven National Expansion

Kindbody is using partners to sell national coverage before it has built a national clinic base. For an employer, that means one fertility benefit can be offered across many markets, while Kindbody keeps its owned clinics in dense core cities and routes patients elsewhere through partner IVF centers tied into its app and care model. That lowers the cash needed for real estate, labs, and staff in every new geography.

• Owned clinics are expensive because IVF requires labs, specialized equipment, and tightly staffed medical teams. Kindbody had 27 owned clinics and IVF labs as of June 2025, but also 400 plus partner clinics across 113 countries, which lets it pitch broader employer coverage without opening hundreds of sites itself.
  1 sacra
• This puts Kindbody between Progyny and Maven. Progyny mainly manages benefits through a clinic network and does not own care delivery. Maven is even more asset light, serving 175 countries through provider partnerships and virtual care. Kindbody keeps more control over the patient experience in its own sites while borrowing network scale from partners.
  1 sacra 3 sacra
• The business impact is distribution. Kindbody served 135 employers as of June 2025, and employer benefits are increasingly central because large companies want one vendor that can cover employees in many places. The hybrid network lets Kindbody win those contracts first, then decide later which markets are worth turning into owned clinics.
  1 sacra

The next phase is a tighter split between flagship markets and network markets. Kindbody is likely to keep building owned clinics where patient density supports strong unit economics, while using partner sites almost everywhere else. If that model holds, the company can keep expanding employer coverage faster than its physical footprint and turn national access into a durable sales advantage.